首页> 外文OA文献 >Association between the methylation status of PCDH17 and the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer

【2h】

Association between the methylation status of PCDH17 and the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer

机译：PCDH17甲基化状态与新乳腺癌中新辅助化疗的关联及新辅助化疗的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
De-Di Kong; Rong-Zhan Fu; Liang Li; Wei Wang; Shi-Bing Wang;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy [J] . Barron Alison U., Hoskin Tanya L., Day Courtney N., JAMA surgery . 2018,第12期

机译：ERBB2阳性或三阴性乳腺癌和乳房病理完全反应对Neoadjuvant化疗的患者患者低结节阳性率
2. BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy [J] . FoedermayrM., SebestaM., RudasM., Cancer chemotherapy and pharmacology. . 2014,第4期

机译：对紫杉烷类新辅助化疗无病理学完全反应的三阴性乳腺癌患者BRCA-1甲基化和TP53突变
3. BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy [J] . FoedermayrM., SebestaM., RudasM., Cancer chemotherapy and pharmacology. . 2014,第4期

机译：三阴性乳腺癌患者的BRCA-1甲基化和TP53突变，没有病原体的新辅助化疗的病理完全反应
4. Optical coherence elastography as a new method for estimation of chemotherapy efficacy on triple-negative breast cancer in the experiment [C] . Anton A. Plekhanov, Marina A. Sirotkina, Alexander A. Sovetsky, International Symposium on Optics and Biophotonics: Saratov Fall Meeting . 2019

机译：光学相干弹性造影作为对实验中三阴性乳腺癌化疗疗效估算的新方法
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy [O] . Hélène Bonsang-Kitzis, Léonor Chaltier, Lisa Belin, 2010

机译：除腋窝淋巴结转移，BMI和更年期状态是新辅助化疗治疗的三阴性乳腺癌的预后决定因素。
7. Efficacy of Neoadjuvant Versus Adjuvant Chemotherapy in Hispanic/Latino (H/L) Women With Local or Locally Advanced Triple-negative Breast Cancer (TNBC) [O] . ALEXANDER PHILIPOVSKIY, JAVIER CORRAL, KUMAR ALOK DWIVEDI, 2019

机译：Neoadjuvant与辅助化疗的疗效在西班牙/拉丁裔（H / L）妇女与当地或局部晚期三重阴性乳腺癌（TNBC）

Association between the methylation status of PCDH17 and the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅